Update: Note that since posting
this survey on September 3, 2004another
major asbestos defendant, Pfizer, Inc, the parent of Quigley Company
(which made asbestos cements), filed for Chapter 11 reorganization.
Pfizer will be protected from future
liability and will pay $405 million into a settlement trust, along
with $100 million in insurance coverage. Again, no provisions have
been made, or even discussed, about the merits of investing a fraction
of this victims fund into medical research. Unfortunately, the adage:
"A pound of prevention is worth a pound of cure" has yet to resonate
in the asbestos manufacturer-insurance-lawyer establishment.
- RGW September 3,
2004 |
|
Results
Posted
BELOW as of March 14,
2006
|
My firm is conducting a survey of asbestos
disease claimants, the results of which I will present to members of
Congress as well the trustees who serve on the several major asbestos
chapter 11 reorganizations.
THIS IS A HYPOTHETICAL SURVEY. THE
RESULTS WILL NOT AFFECT YOUR PAST OR FUTURE CLAIMS, YOUR CONTRACT WITH
THIS OR ANY OTHER LAW OFFICE, OR ANY OTHER OBLIGATION. YOU DO NOT NEED TO
GIVE YOUR NAME. WE WILL NOT SHARE ANY EMAIL
ADDRESSES.
Your voice must be heard. Please take a
moment to answer the survey below regarding whether a slice of the $12-22
billion proposed asbestos victims bankruptcy trusts should set aside a
small percentage for asbestos cancer research (detection, prevention,
treatment and cure).
This is a survey that is intended for
patients diagnosed with asbestos-related disease and/or their family
members. The Mesothelioma Applied Research Foundation (www.marf.org)
will use this information to both 1) lobby congress to appropriate money
for asbestos medical research and 2) provide a basis for the trustees on
the asbestos creditors committees for the ongoing chapter 11 debt
reorganizations to allocate a percentage of the settlement trust for
medical research. It is my belief that asbestos cancer victims want
advocates who will fight hard not only for compensation, but also for a
medical cure.
The National Cancer Institute, whose budget
in 2004 is over $27.8 billion, over the past three years on average has
funded basic and applied research on mesothelioma detection, prevention
and treatment at about $1.7 million (most on clinical trials). Congress
over the past several years has appropriated over $1.5 billion to the
Department of Defense (DOD) for the funding and operation of breast and
prostate cancer research and treatment programs. The Department of
Veterans Affairs does not have an ongoing program for the treatment of
veterans stricken with mesothelioma, even though about 32% of the 2,500 to
3,000 Americans diagnosed with mesothelioma were exposed to asbestos while
serving in the US Navy or working in naval shipyards (truly making
mesothelioma a "war-related disability"). Although since the 1970's
asbestos litigation has absorbed over $70 billion, the asbestos industry
has never funded any research programs to help diagnose, prevent or treat
mesothelioma. Congress has never appropriated any funding to any federal
agency for the purpose of diagnosing or treating mesothelioma.
There are currently over 10 major former
asbestos defendants who are restructuring (relieving) their asbestos
liabilities in the Chapter 11 bankruptcy courts.* Each debtor will
eventually set aside a sum of money in trust to be paid out to asbestos
disease claimants. Although we will not know the exact dollar value of
the respective trusts until they are approved by the courts, insiders
estimate that the total value of eleven (11) of the future asbestos trust
funds will hover between $12 and $2e billion. Over 30 companies have
sought shelter in the Chapter 11 bankruptcy courts since 2000. For many
of these debtors, business is thriving and profits are good.
For each debtor's litigation, the
bankruptcy court has chosen a group of creditors (mainly asbestos trial
lawyers) to serve as trustees for present and future asbestos claimants.
The trustees have a fiduciary duty to manage the trust fund in the
interest of past, present and future asbestos claimants, who are in effect
"creditors." The bankruptcy code does not expressly mandate that the
trustees set aside funds from the trust for medical research on
diagnosing, preventing or treating mesothelioma. In fact, many trustees
can credibly argue that if they attempted to set aside money for research,
they might be violating their express fiduciary duty to asbestos victim
creditors (the premise being that creditors want money only). For each
debtor bankruptcy, there are multiple creditors committees wrangling to
snatch as big a piece of the debtor's pie as possible.
In order to approve a trust's distribution
plan, the trustees generally need the approval of a majority of the
asbestos claimants. MARF advocates two things: (1) Congress needs to
immediately amend Section 524g of the Bankruptcy Code to expressly
authorize the trustees to set aside a reasonable percentage of the trust
for asbestos disease medical research, and (2) until such congressional
action is taken, trustees for present and future asbestos claimants should
immediately exercise their implied powers to protect the rights of
asbestos victims by setting aside a reasonable percentage of the trust for
asbestos disease medical research.
Because a trustee may be reluctant to
"chart new waters," we are conducting this poll among asbestos disease
claimants (the beneficiaries of the trusts) to learn your preference on
whether money should be set aside for medical research. Theoretically,
the settlement trusts belong to those sickened by asbestos. Common sense
dictates that a trustee for future claimants would applaud efforts by past
and present disease trustees to dedicate a slice of the debtor's trust to
a fund designed to either prevent future claimants or extend the latters'
lives.
Please take a moment to answer the
following questions. This survey is for patients with asbestos disease and
members of their family.
1. Disease status
|
I have:
|
|
A relative of mine has: |
|
|
|
|
2. I would like a percentage of all
bankruptcy settlement trusts to allocate a percentage of the trust to a
fund to be used for basic and applied medical research on asbestos cancer
detection, prevention and treatment.** Yes
No Don't Know
Comments
|
As of March 14,
2006
85%
- YES 9% - NO
6% - Undecided |
3. If you answered "yes" to Question No. 2
above, please state the percentage of the trust fund you want to be
allocated to asbestos cancer medical research:
%
|
As of March 14,
2006
18%
wanted between .05% and 9.9% 56%
wanted
between 10% and
29.9% 26%
wanted
between 30% and
100% |
4. Would you be willing to allocate a
percentage of the future gross settlements collected in your lawsuit to a
trust fund managed by the National Institutes of Health to be used to fund
medical research on the prevention, detection, treatment and cure of
mesothelioma? Yes
No Don't Know
Comments
|
As of March 14,
2006
71%- YES
14% - NO 15% - Undecided |
5. If you answered Question No. 4 with a
"yes", how much would you be willing to set aside:
%
|
As of March 14,
2006
24%
wanted
between .05% and 9.9% 62%
wanted
between 10% and 29.9% 14%
wanted
between 30% and 100% |
6. Do you think your legal counsel should
donate a portion of their fee from all future settlements collected to a
trust fund managed by the National Institutes of Health to be used to fund
medical research on the prevention, detection, treatment and cure of
mesothelioma? Yes
No Don't Know
Comments
|
As of March 14,
2006
77%
- YES 14% - NO
9% - Undecided |
7. If you answered Question No. 6 with a
"yes", how much do you think your lawyers should donate
%
|
As of March 14,
2006
24%
wanted
between .05% and 9.9% 59%
wanted
between 10% and
29.9% 17%
wanted
between 30% and
100% |
8. Would you agree to donate a percentage
of your future settlements if your lawyers also agreed to match the same
percentage donation from their legal fee? Yes
No Don't Know
Comments
|
As of March 14,
2006
79% -
YES 12% - NO
9% - Undecided |
9. Do you think the asbestos companies
should have to pay a surcharge or tax on any settlement or judgment they
disburse to an asbestos claimant, the revenues from which will be
deposited into a trust fund managed by the National Institutes of Health
to be used to fund medical research on the prevention, detection,
treatment and cure of mesothelioma? Yes
No Don't Know
Comments
|
As of March 14,
2006
79%
- YES 11% - NO
10% - Undecided |
If you answered "yes" to the question, what
percentage of any settlement should the defendant in an asbestos injury or
wrongful death lawsuit be forced to pay?
%
|
As of March 14,
2006
16%
wanted
between .05% and 9.9% 58%
wanted
between 10% and
29.9% 26%
wanted
between 30% and 100% |
10. Do you believe an asbestos defendant
who settles with a claimant should pay a "cancer tax" on the amount of
each settlement, the revenue from which will be deposited in a trust for
the purpose of funding peer reviewed medical research on the detection,
treatment and cure of mesothelioma? If so, what percentage of the
settlement should the asbestos defendant pay into the medical research
trust? %
|
As of March 14,
2006
17%
wanted
between .05% and 9.9% 66%
wanted
between 10% and
29.9% 17%
wanted
between 30% and 100% |
* More than 30 companies are now in the
process of creating asbestos settlement trusts. The combined value of the
anticipated asbestos trusts from the 12 debtors below is estimated to be
between $11 and $21 billion. Because of certain liability-saving
advantages of chapter 11 reorganization, several other current asbestos
defendants have hinted that they may also see reorganization of their
asbestos debts in the bankruptcy courts. Chapter 11 reorganizations for
asbestos debtors generally take 5 to 6 years.
Armstrong World Industries Babcock & Wilcox Owens Corning Fiberglas Fibreboard Corporation W.R. Grace & CO. Kaiser Aluminum Federal Mogul United States Gypsum Pittsburg Corning Corp./Pittsburg Plate and Glass North American Refractory Co/Honeywell Halliburton/Dresser Industries/Harbison Walker Refractories Co. A.P. Green
** The medical
trust will be administered by an "asbestos medical czar" selected by the
Director of the National Institutes of Health after collaborating with the
Center for Disease Control, National Heart Lung and Blood Institute, the
National Cancer Institute, the Department of Defense, and the Department
of Veterans Affairs. Targeted research grants will be awarded after
peer-review by a committee of doctors and scientists from the
aforementioned Institutes/Agencies and by patient advocates selected by
the director of the NIH .
Thank you.
RGW
If you are not represented by counsel and would like
legal information, please provided a contact phone number or email in the
box below. Or call us at (800) 831-9399
Contact Information
***
POSTED AUGUST 25, 2004 ****
|